1. Home
  2. LNTH vs PSN Comparison

LNTH vs PSN Comparison

Compare LNTH & PSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNTH
  • PSN
  • Stock Information
  • Founded
  • LNTH 1956
  • PSN 1944
  • Country
  • LNTH United States
  • PSN United States
  • Employees
  • LNTH N/A
  • PSN N/A
  • Industry
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • PSN EDP Services
  • Sector
  • LNTH Health Care
  • PSN Technology
  • Exchange
  • LNTH Nasdaq
  • PSN Nasdaq
  • Market Cap
  • LNTH 7.5B
  • PSN 7.8B
  • IPO Year
  • LNTH 2015
  • PSN 2019
  • Fundamental
  • Price
  • LNTH $78.95
  • PSN $65.26
  • Analyst Decision
  • LNTH Strong Buy
  • PSN Buy
  • Analyst Count
  • LNTH 5
  • PSN 11
  • Target Price
  • LNTH $133.80
  • PSN $87.44
  • AVG Volume (30 Days)
  • LNTH 1.3M
  • PSN 1.4M
  • Earning Date
  • LNTH 05-07-2025
  • PSN 04-30-2025
  • Dividend Yield
  • LNTH N/A
  • PSN N/A
  • EPS Growth
  • LNTH N/A
  • PSN 50.29
  • EPS
  • LNTH 3.53
  • PSN 2.35
  • Revenue
  • LNTH $1,536,699,000.00
  • PSN $6,769,260,000.00
  • Revenue This Year
  • LNTH $5.81
  • PSN $5.09
  • Revenue Next Year
  • LNTH $12.26
  • PSN $4.47
  • P/E Ratio
  • LNTH $22.69
  • PSN $27.78
  • Revenue Growth
  • LNTH 12.53
  • PSN 16.61
  • 52 Week Low
  • LNTH $74.34
  • PSN $54.56
  • 52 Week High
  • LNTH $126.89
  • PSN $114.68
  • Technical
  • Relative Strength Index (RSI)
  • LNTH 27.93
  • PSN 54.38
  • Support Level
  • LNTH $78.61
  • PSN $63.07
  • Resistance Level
  • LNTH $83.60
  • PSN $64.62
  • Average True Range (ATR)
  • LNTH 3.87
  • PSN 2.10
  • MACD
  • LNTH -3.13
  • PSN -0.10
  • Stochastic Oscillator
  • LNTH 1.12
  • PSN 46.98

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.

Share on Social Networks: